These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20334889)

  • 1. Myxoma and vaccinia viruses exploit different mechanisms to enter and infect human cancer cells.
    Villa NY; Bartee E; Mohamed MR; Rahman MM; Barrett JW; McFadden G
    Virology; 2010 Jun; 401(2):266-79. PubMed ID: 20334889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myxoma and vaccinia viruses bind differentially to human leukocytes.
    Chan WM; Bartee EC; Moreb JS; Dower K; Connor JH; McFadden G
    J Virol; 2013 Apr; 87(8):4445-60. PubMed ID: 23388707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA Helicase A/DHX9 Forms Unique Cytoplasmic Antiviral Granules That Restrict Oncolytic Myxoma Virus Replication in Human Cancer Cells.
    Rahman MM; Gutierrez-Jensen AD; Glenn HL; Abrantes M; Moussatche N; McFadden G
    J Virol; 2021 Jun; 95(14):e0015121. PubMed ID: 33952639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myxoma virus oncolytic efficiency can be enhanced through chemical or genetic disruption of the actin cytoskeleton.
    Irwin CR; Favis NA; Agopsowicz KC; Hitt MM; Evans DH
    PLoS One; 2013; 8(12):e84134. PubMed ID: 24391902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity.
    Correa RJ; Komar M; Tong JG; Sivapragasam M; Rahman MM; McFadden G; Dimattia GE; Shepherd TG
    Gynecol Oncol; 2012 May; 125(2):441-50. PubMed ID: 22306204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccinia virus dissemination requires p21-activated kinase 1.
    Andrade LG; Albarnaz JD; Mügge FL; David BA; Abrahão JS; da Fonseca FG; Kroon EG; Menezes GB; McFadden G; Bonjardim CA
    Arch Virol; 2016 Nov; 161(11):2991-3002. PubMed ID: 27465567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the myxoma virus plaque phenotype by vaccinia virus protein F11.
    Irwin CR; Evans DH
    J Virol; 2012 Jul; 86(13):7167-79. PubMed ID: 22514354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myeloid leukemia targeting by myxoma virus in vivo depends on cell binding but not permissiveness to infection in vitro.
    Madlambayan GJ; Bartee E; Kim M; Rahman MM; Meacham A; Scott EW; McFadden G; Cogle CR
    Leuk Res; 2012 May; 36(5):619-24. PubMed ID: 22341701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myxoma virus M156 is a specific inhibitor of rabbit PKR but contains a loss-of-function mutation in Australian virus isolates.
    Peng C; Haller SL; Rahman MM; McFadden G; Rothenburg S
    Proc Natl Acad Sci U S A; 2016 Apr; 113(14):3855-60. PubMed ID: 26903626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of host DEAD-box RNA helicases that regulate cellular tropism of oncolytic Myxoma virus in human cancer cells.
    Rahman MM; Bagdassarian E; Ali MAM; McFadden G
    Sci Rep; 2017 Nov; 7(1):15710. PubMed ID: 29146961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations Near the N Terminus of Vaccinia Virus G9 Protein Overcome Restrictions on Cell Entry and Syncytium Formation Imposed by the A56/K2 Fusion Regulatory Complex.
    Cotter CA; Moss B
    J Virol; 2020 May; 94(10):. PubMed ID: 32132239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Host Restriction Factor Interferon-Inducible Transmembrane Protein 3 Inhibits Vaccinia Virus Infection.
    Li C; Du S; Tian M; Wang Y; Bai J; Tan P; Liu W; Yin R; Wang M; Jiang Y; Li Y; Zhu N; Zhu Y; Li T; Wu S; Jin N; He F
    Front Immunol; 2018; 9():228. PubMed ID: 29503647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccinia virus strain differences in cell attachment and entry.
    Bengali Z; Townsley AC; Moss B
    Virology; 2009 Jun; 389(1-2):132-40. PubMed ID: 19428041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myxoma virus sensitizes cancer cells to gemcitabine and is an effective oncolytic virotherapeutic in models of disseminated pancreatic cancer.
    Wennier ST; Liu J; Li S; Rahman MM; Mona M; McFadden G
    Mol Ther; 2012 Apr; 20(4):759-68. PubMed ID: 22233582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral-mediated oncolysis is the most critical factor in the late-phase of the tumor regression process upon vaccinia virus infection.
    Weibel S; Raab V; Yu YA; Worschech A; Wang E; Marincola FM; Szalay AA
    BMC Cancer; 2011 Feb; 11():68. PubMed ID: 21320309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Novel Myxoma Virus C7-Like Host Range Factor That Enabled a Species Leap from Rabbits to Hares.
    Águeda-Pinto A; Kraberger S; Everts A; Gutierrez-Jensen A; Glenn HL; Dalton KP; Podadera A; Parra F; Martinez-Haro M; Viñuelas JA; Varsani A; McFadden G; Rahman MM; Esteves PJ
    mBio; 2022 Apr; 13(2):e0346121. PubMed ID: 35352978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The membrane fusion step of vaccinia virus entry is cooperatively mediated by multiple viral proteins and host cell components.
    Laliberte JP; Weisberg AS; Moss B
    PLoS Pathog; 2011 Dec; 7(12):e1002446. PubMed ID: 22194690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA Polymerase Mutations Selected during Experimental Evolution Enhance Replication of a Hybrid Vaccinia Virus with an Intermediate Transcription Factor Subunit Replaced by the Myxoma Virus Ortholog.
    Stuart CA; Zhivkoplias EK; Senkevich TG; Wyatt LS; Moss B
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30045995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myxoma Virus dsRNA Binding Protein M029  Inhibits the Type I IFN-Induced Antiviral State in a  Highly Species-Specific Fashion.
    Rahman MM; McFadden G
    Viruses; 2017 Feb; 9(2):. PubMed ID: 28157174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear Export Inhibitor Selinexor Enhances Oncolytic Myxoma Virus Therapy against Cancer.
    Rahman MM; van Oosterom F; Enow JA; Hossain M; Gutierrez-Jensen AD; Cashen M; Everts A; Lowe K; Kilbourne J; Daggett-Vondras J; Karr TL; McFadden G
    Cancer Res Commun; 2023 Jun; 3(6):952-968. PubMed ID: 37377603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.